エル・ティー・エスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/04/15 | 2,300 | 2,300 | 2,257 | 2,282 | -19 | -0.8% | 10,900 |
2024/04/12 | 2,340 | 2,365 | 2,301 | 2,301 | -39 | -1.7% | 12,600 |
2024/04/11 | 2,377 | 2,377 | 2,340 | 2,340 | -37 | -1.6% | 3,800 |
2024/04/10 | 2,391 | 2,438 | 2,377 | 2,377 | +7 | +0.3% | 9,000 |
2024/04/09 | 2,363 | 2,403 | 2,327 | 2,370 | +29 | +1.2% | 22,000 |
2024/04/08 | 2,324 | 2,387 | 2,324 | 2,341 | +43 | +1.9% | 10,400 |
2024/04/05 | 2,315 | 2,373 | 2,298 | 2,298 | -67 | -2.8% | 25,300 |
2024/04/04 | 2,388 | 2,404 | 2,362 | 2,365 | -23 | -1% | 10,900 |
2024/04/03 | 2,420 | 2,431 | 2,354 | 2,388 | -68 | -2.8% | 16,800 |
2024/04/02 | 2,426 | 2,470 | 2,396 | 2,456 | +32 | +1.3% | 20,400 |
2024/04/01 | 2,525 | 2,534 | 2,424 | 2,424 | -79 | -3.2% | 19,600 |
2024/03/29 | 2,358 | 2,510 | 2,358 | 2,503 | +146 | +6.2% | 34,700 |
2024/03/28 | 2,340 | 2,389 | 2,333 | 2,357 | +31 | +1.3% | 36,900 |
2024/03/27 | 2,327 | 2,367 | 2,319 | 2,326 | -7 | -0.3% | 20,600 |
2024/03/26 | 2,300 | 2,338 | 2,276 | 2,333 | +23 | +1% | 27,100 |
2024/03/25 | 2,344 | 2,365 | 2,310 | 2,310 | -44 | -1.9% | 25,600 |
2024/03/22 | 2,390 | 2,390 | 2,345 | 2,354 | -30 | -1.3% | 29,500 |
2024/03/21 | 2,367 | 2,395 | 2,337 | 2,384 | +9 | +0.4% | 33,700 |
2024/03/19 | 2,398 | 2,402 | 2,355 | 2,375 | -17 | -0.7% | 27,600 |
2024/03/18 | 2,400 | 2,419 | 2,360 | 2,392 | -24 | -1% | 39,200 |
2024/03/15 | 2,471 | 2,471 | 2,415 | 2,416 | -105 | -4.2% | 35,500 |
2024/03/14 | 2,553 | 2,564 | 2,511 | 2,521 | -41 | -1.6% | 26,900 |
2024/03/13 | 2,619 | 2,643 | 2,535 | 2,562 | -80 | -3% | 32,000 |
2024/03/12 | 2,552 | 2,642 | 2,551 | 2,642 | +55 | +2.1% | 27,100 |
2024/03/11 | 2,635 | 2,647 | 2,565 | 2,587 | -75 | -2.8% | 29,400 |
2024/03/08 | 2,673 | 2,697 | 2,626 | 2,662 | -33 | -1.2% | 29,000 |
2024/03/07 | 2,773 | 2,803 | 2,688 | 2,695 | -78 | -2.8% | 32,000 |
2024/03/06 | 2,649 | 2,774 | 2,630 | 2,773 | +112 | +4.2% | 39,800 |
2024/03/05 | 2,610 | 2,664 | 2,586 | 2,661 | +49 | +1.9% | 21,300 |
2024/03/04 | 2,586 | 2,640 | 2,573 | 2,612 | +52 | +2% | 28,000 |
2024/03/01 | 2,647 | 2,647 | 2,556 | 2,560 | -78 | -3% | 30,000 |
2024/02/29 | 2,650 | 2,653 | 2,512 | 2,638 | -59 | -2.2% | 78,300 |
2024/02/28 | 2,700 | 2,830 | 2,673 | 2,697 | +97 | +3.7% | 68,400 |
2024/02/27 | 2,610 | 2,639 | 2,575 | 2,600 | -25 | -1% | 21,700 |
2024/02/26 | 2,630 | 2,646 | 2,569 | 2,625 | -18 | -0.7% | 25,900 |
2024/02/22 | 2,683 | 2,683 | 2,621 | 2,643 | -17 | -0.6% | 28,500 |
2024/02/21 | 2,772 | 2,772 | 2,632 | 2,660 | -105 | -3.8% | 34,000 |
2024/02/20 | 2,727 | 2,776 | 2,684 | 2,765 | +78 | +2.9% | 34,900 |
2024/02/19 | 2,570 | 2,711 | 2,551 | 2,687 | +118 | +4.6% | 37,300 |
2024/02/16 | 2,486 | 2,601 | 2,427 | 2,569 | +96 | +3.9% | 49,800 |
2024/02/15 | 2,550 | 2,593 | 2,473 | 2,473 | -105 | -4.1% | 38,700 |
2024/02/14 | 2,500 | 2,655 | 2,500 | 2,578 | -257 | -9.1% | 117,400 |
2024/02/13 | 2,867 | 2,867 | 2,751 | 2,835 | +32 | +1.1% | 35,500 |
2024/02/09 | 2,830 | 2,888 | 2,780 | 2,803 | -28 | -1% | 18,100 |
2024/02/08 | 2,820 | 2,848 | 2,698 | 2,831 | -32 | -1.1% | 30,200 |
2024/02/07 | 2,899 | 2,902 | 2,856 | 2,863 | -47 | -1.6% | 7,900 |
2024/02/06 | 2,950 | 2,950 | 2,896 | 2,910 | -40 | -1.4% | 7,500 |
2024/02/05 | 2,927 | 2,950 | 2,893 | 2,950 | +35 | +1.2% | 6,600 |
2024/02/02 | 2,870 | 2,923 | 2,870 | 2,915 | +25 | +0.9% | 9,100 |
2024/02/01 | 2,910 | 2,964 | 2,880 | 2,890 | -61 | -2.1% | 7,500 |
151~
200
件表示中 / 1694件
類似銘柄と比較する
現在ご覧いただいている「LTS」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
LTS | 230,600円 | +34.8% | +52.7% | 1.30% | 10.71倍 | 2.74倍 |
|
ビジネスプロセス可視化・改善・実行支援など展開、ITビジネスマッチング「アサインナビ」も |
メドピア | 49,100円 | -17.1% | -35.1% | 0.92% | 21.33倍 | 1.13倍 |
|
医師向け情報サイト運営、製薬会社の広告料が収益源。法人向け医療相談や特定保健指導も展開 |
FCE | 97,200円 | +14.9% | +29.6% | 1.44% | 16.86倍 | 3.15倍 |
|
業務改善用RPAソフトでDX支援。クラウドサービスでeラーニング展開。配当性向25%目安 |
MDNT | 4,000円 | +21.1% | - | 0.00% | - | 2.04倍 |
|
東大医科研発。がん免疫細胞療法の細胞加工が核。医薬品開発、医薬品受託製造(CDMO)も |
ZETA | 40,900円 | -54.0% | - | 1.71% | 282.07倍 | 7.62倍 |
|
ZETAを子会社化しビッグデータ活用の推奨商品表示(CX改善)が柱に。ネット広告は撤退 |
市場注目の銘柄
チャート関連のコラム